Mercedes Benz Group's Daimler South East Asia has produced its Ocean Protocol pilot-based Acentrik blockchain platform.
A non-fungible token (NFT) represents each Acentrik dataset and a metadata hash is stored in it.
Acentrik is squarely targeted at enterprise users, including Know Your Business and extensive access controls.
Since Acentrik is not domain specific, the platform could be used for insurance information, clinical trials data, or anything else.
Although consumers can use a stablecoin rather than a cryptocurrency to pay for data, public blockchains like Polygon or the Ethereum Rinkeby test network carry out the transactions.
However, Polygon gas fees must be paid with the MATIC cryptocurrency. The underlying data can be stored on IPFS or AWS S3.


Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



